Graph Neural Networks - Drug-target prediction

Introduction

Graph Neural Networks (GNNs) have profound implications for drug discovery, as they can represent molecules and proteins as interconnected graphs and predict binding affinities with high precision. The guide below defines the basic concepts of Graph Neural Networks, along with its applications, for researchers who are developing drug screening systems.

What Are Graph Neural Networks?

Traditional ML treats molecules as flat SMILES strings or images, ignoring atomic connectivity. GNNs represent:

  • Drugs: Atoms as nodes, bonds as edges
  • Proteins: Amino acids/residues as nodes, spatial contacts as edges
  • Prediction: Binding affinity (Kd, Ki, IC50) as graph regression task

GNNs use message passing to aggregate neighbor information:

Node embedding_i = f(embedding_i, ∑_{neighbors} message_j→i)

Core GNN Architectures for Drug-Target Prediction

Graph Convolutional Networks (GCN)

Simplest GNN—each node updates via weighted sum of 1-hop neighbors.
Basic PyTorch Geometric GCN for Drug Molecules:


    import torch  
    from torch_geometric.nn import GCNConv  
    from torch_geometric.data import Data 
    
    class DrugGCN(torch.nn.Module):  
        def __init__(self, num_features, hidden_dim=128, num_classes=1):  
            super().__init__()  
            self.conv1 = GCNConv(num_features, hidden_dim)  
            self.conv2 = GCNConv(hidden_dim, hidden_dim)  
            self.fc = torch.nn.Linear(hidden_dim, num_classes) 
            
        def forward(self, data): 
            x, edge_index = data.x, data.edge_index 
            x = torch.relu(self.conv1(x, edge_index)) 
            x = torch.relu(self.conv2(x, edge_index)) 
            x = torch.max(x, dim=0)[0]  # Global pooling  
            return self.fc(x)
                      

Graph Attention Networks (GAT)

Learns edge weights dynamically, focusing on pharmacophore-critical atoms.

GAT Layer Example:


    from torch_geometric.nn import GATConv 
    self.gat1 = GATConv(num_features, hidden_dim, heads=4) 
    # Multi-head attention captures diverse interactions
                      

Dual-Graph Architectures (Drug + Target)

GraphDTA-style Model (state-of-the-art benchmark):

  1. Drug Graph: SMILES → RDKit → PyTorch Geometric ↓ GCN/GAT layers → Drug embedding (256-dim)
  2. Protein Sequence: ESM-2 embedding or 1D-CNN ↓ Transformer/CNN → Protein embedding (256-dim)
  3. Combine: Concatenate → MLP → Binding affinity prediction

Complete Drug-Target GNN:


    class GraphDTA(torch.nn.Module):  
    def __init__(self):  
        super().__init__()  
        # Drug GNN  
        self.drug_gnn = GCNConv(9, 256) # Atomic features  
        # Protein CNN  
        self.protein_cnn = torch.nn.Conv1d(20, 32, 5)  
        self.fc = torch.nn.Sequential( 
            torch.nn.Linear(512, 1024), 
            torch.nn.ReLU(), 
            torch.nn.Linear(1024, 1) # pKd prediction  
        ) 
        
    def forward(self, drug_data, protein_seq): 
        drug_emb = self.drug_gnn(drug_data.x, drug_data.edge_index) 
        prot_emb = self.protein_cnn(protein_seq) 
        combined = torch.cat([drug_emb.mean(0), prot_emb.mean(0)]) 
        return self.fc(combined)
                      

Key Applications and Datasets

Task Datasets Typical GNN Choice Metrics
Binding Affinity Davis, KIBA GraphDTA, GAT PearsonR: 0.89, RMSE: 0.18
Virtual Screening BindingDB GCN + ESM-2 AUROC: 0.92
Drug Repurposing DrugBank Multi-task GNN Hit Rate: 15% improvement
Adverse Effects SIDER Graph + Text GNN AUPR: 0.78

Feature Comparison: GNN vs Traditional ML

Method Molecular Representation Protein Representation Performance Scalability
Random Forest ECFP fingerprints Sequence one-hot Baseline High
CNN (1D/2D) SMILES/Image Sequence CNN Good Medium
GNN (GraphDTA) Atomic graph ESM-2 + CNN SOTA High
Transformer SMILES tokens ProteinLanguageModel Very Good Low

Implementation Workflow

  • Data Prep: RDKit (drug graphs) + ESM-2 (protein embeddings)
  • GNN Training: PyTorch Geometric + PyTorch
  • Evaluation: 5-fold CV on KIBA/Davis
  • Deployment: ONNX export → Snakemake/Nextflow pipeline

Snakemake Rule Example:


    rule train_gnn: 
        input: "data/processed/drug_protein_pairs.csv" 
        output: "models/graphdta_epoch50.pt" 
        shell: "python train_graphdta.py --data {input} --out {output}"
                  

Performance Characteristics

  • Small Molecule Screening (10K compounds):
    • GNN: 92% AUROC, 3 GPU hours
    • Traditional Docking: 87% AUROC, 48 CPU hours
  • Large-Scale Repurposing (1M compounds):
    • GNN screening: 2 hours on 4 A100s
    • Top-100 hits → Wet-lab validation

When to Choose GNNs

Choose Graph Neural Networks when:
• 3D structural data available (AlphaFold)
• Multi-task learning (affinity + ADMET)
• Drug repurposing campaigns
• Scaffold hopping required
• Existing CNN performance plateaued
Consider Alternatives when:
• Limited compute (XGBoost)
• Very large chemical spaces (>10M)
• No structural protein data

SyncBio Bioinformatics Implementation

SyncBio Bioinformatics integrates GNNs into drug discovery pipelines:

Drug-Target Prediction Pipeline:

AlphaFold3 structures → PyTorch Geometric GNNs → Nextflow cloud deployment → 10K compounds/day → VariantML-Pipe integration → Patient-specific drugs

Key Results:

  • KIBA Benchmark: 0.91 PearsonR (SOTA)
  • Screened 50K repurposing candidates
  • Identified 12 novel kinase inhibitors
  • Production via Nextflow + AWS Batch

GNNs power SyncBio's PersonalizedRx-Workflow, predicting patient-specific drug-target interactions for precision medicine applications.

Ready to Implement?

Let our team help you leverage these technologies.

Contact Us